drugset / Trial / NCT00759421

Exploratory Cognition Study of Sertindole in Patients With Schizophrenia

NCT00759421

Phase 3 Completed 96 enrolled H. Lundbeck A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this exploratory study is to evaluate the effects of sertindole and olanzapine on neurocognitive functioning in patients with schizophrenia.

Timeline

Start
2006-10
Primary completion
2008-03
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Olanzapine Small molecule 10 mg Oral
Comparator Olanzapine Small molecule 20 mg Oral
Subject Sertindole Small molecule 12 mg Oral
Subject Sertindole Small molecule 20 mg Oral

Indications